Breast Cancer Management

Aims & Scope

Breast Cancer Management (ISSN: 1758-1923) addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic.

The journal also highlights significant advances in basic and translational research, and places them in context for future therapy.

Breast Cancer Management provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease.

Recent research findings and advances clinical practice in the field are reported and analyzed by international experts.

The journal presents this information in clear, accessible formats.

All articles are subject to independent review by a minimum of three independent experts.

Unsolicited article proposals are welcomed and authors are required to comply fully with the journal’s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.

Coverage includes: Diagnosis and imaging, Surgical approaches, Radiotherapy, Systemic therapies, Cancer clinical trials, Genetic aspects of disease, Personalized medicine, Translational research and biomarker studies, Management of psychological distress, Epidemiological studies, Pharmacoeconomics, Evidence-based treatment guidelines.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2024	0.40

Journal Rank

Year	Value
2024	25325

Journal Citation Indicator

Year	Value
2024	7

SJR (SCImago Journal Rank)

Year	Value
2024	0.140

Quartile

Year	Value
2024	Q4

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• How Can We Best Respect Patient Autonomy in Breast Cancer Treatment Decisions?

  Citation: 36

  Authors: Kathryn A, Allison W, Sarah T, Reshma

• Real and artificial controversies in breast cancer screening

  Citation: 34

  Authors: Stephen W, Tony Hsiu-Hsi, Robert A, Amy Ming-Fang, Laszlo

• Current and Future Methods for Measuring Breast Density: A Brief Comparative Review

  Citation: 33

  Authors: Mark A, Peter J, Neb, Maeve, Mark E, Gretchen L

• Mimicking pregnancy as a strategy for breast cancer prevention

  Citation: 28

  Authors: Julia, Christina, David, Irma H, Johana E, Fathima, Ricardo Lopez, Yanrong, Patricia A, Lucas T, Jose

• Molecular Breast Imaging: An Emerging Modality for Breast Cancer Screening

  Citation: 27

  Authors: Michael K

• Long-term benefits of breast screening

  Citation: 26

  Authors: Stephen W, Amy Ming-Fang, Tony Hsiu-Hsi, Sam Li-Sheng, Sherry Yueh-Hsia, Jean Jean-Yu, Robert A, Bedrich, Laszlo

• Proton Therapy for Breast Cancer: Progress & Pitfalls

  Citation: 21

  Authors: Kimberly S, Robert W

• S1P Promotes Breast Cancer Progression by Angiogenesis and Lymphangiogenesis

  Citation: 19

  Authors: Partha, Rajesh, Kazuaki

• The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer

  Citation: 17

  Authors: Gregory, Neha, Bruce, Robin

• The Use of Chemosensitizers to Enhance the Response to Conventional Therapy in Triple-Negative Breast Cancer Patients

  Citation: 16

  Authors: Fouzia, Keely May, Hironobu

---